Cargando…

Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon

INTRODUCTION: Accurate evaluation of estrogen and progesterone receptors and HER2 is critical when diagnosing invasive breast cancer for optimal treatment. The current evaluation method is via immunohistochemistry (IHC). In this paper, we compared results of ER, PR, and HER2 from microarray gene exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fakhri, Ghina B., Akel, Reem S., Khalil, Maya K., Mukherji, Deborah A., Boulos, Fouad I., Tfayli, Arafat H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020516/ https://www.ncbi.nlm.nih.gov/pubmed/30009057 http://dx.doi.org/10.1155/2018/8530318

Ejemplares similares

Paraneoplastic Pemphigus as a First Manifestation of an Intra-Abdominal Follicular Dendritic Cell Sarcoma: Rare Case and Review of the Literature
por: Akel, Reem, et al.
Publicado: (2018)

Burnout among Lebanese Oncologists: Prevalence and Risk Factors
por: Salem, Rana, et al.
Publicado: (2018)

Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon
por: Fakhri, Ghina, et al.
Publicado: (2021)

Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report
por: Fakhri, Ghina, et al.
Publicado: (2017)

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay
por: Mouttet, D., et al.
Publicado: (2016)

Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)

Prevalence of the epidermal growth factor receptor mutations in lung adenocarcinoma patients from the Middle East region
por: Tfayli, Arafat Hussein, et al.
Publicado: (2019)

Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma
por: de Souza, Ana Amélia, et al.
Publicado: (2019)

The Core Needle and Surgical Biopsy Concordance to Detect Estrogen, Progesterone, and Her-2 Receptors in Breast Cancer: A Comparative Study
por: Ensani, Fereshteh, et al.
Publicado: (2017)

Prevalence and Correlates of Complementary and Alternative Medicine Use among Patients with Lung Cancer: A Cross-Sectional Study in Beirut, Lebanon
por: Naja, Farah, et al.
Publicado: (2017)

Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer
por: Ko, Eunkyung, et al.
Publicado: (2010)

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
por: Yu, Ke-Da, et al.
Publicado: (2015)

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
por: Zhao, Shen, et al.
Publicado: (2019)

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

Estrogen Receptor Mutations and Changes in Estrogen Receptor and Progesterone Receptor Protein Expression in Metastatic or Recurrent Breast Cancer
por: Umekita, Yoshihisa, et al.
Publicado: (1998)

Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
por: Liu, Xi-Yu, et al.
Publicado: (2018)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Progesterone receptor modulates estrogen receptor-α action in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2015)

Expression of Estrogen Receptors (ER), Progesterone Receptors (PR) and HER-2/neu receptors in Endometrial Carcinoma and their associations with histological types, grades and stages of the tumor
por: Waqar, Samina, et al.
Publicado: (2018)

Late-Onset Inflammatory Bowel Disease-Like Syndrome after Ipilimumab Therapy: A Case Report
por: Akel, Reem, et al.
Publicado: (2017)

Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
por: Perkins, Meghan S., et al.
Publicado: (2022)

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer
por: Fan, Ying, et al.
Publicado: (2015)

Progesterone and Estrogen Receptors in Neurofibromas of Patients with NF1
por: Geller, Mauro, et al.
Publicado: (2008)

Estrogen and Progesterone Receptors in Endometrium in Women with Unexplained Infertility
por: Godinjak, Zulfo, et al.
Publicado: (2014)

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014)

RIME proteomics of estrogen and progesterone receptors in breast cancer
por: D’Santos, Clive, et al.
Publicado: (2015)

Expression of estrogen and progesterone receptors in papillary thyroid carcinoma
por: Jalali-Nadoushan, Mohammad-Reza, et al.
Publicado: (2016)

Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer
por: Kalinina, Tatiana, et al.
Publicado: (2021)

The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer
por: Erkılınç, Gamze, et al.
Publicado: (2023)

Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma
por: Toi, Pampa Ch, et al.
Publicado: (2018)

Relationship of Tubule Formation, Indian File Pattern and Apocrine Change With Estrogen and Progesterone Receptors and HER2 Immunostaining
por: Singh, Divya, et al.
Publicado: (2022)

Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer
por: Kabir, Farruk M. Lutful, et al.
Publicado: (2017)

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
por: Mehmeti, Meliha, et al.
Publicado: (2015)

Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
por: Hefti, Marco M, et al.
Publicado: (2013)

Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors
por: Méndez-López, Luis Fernando, et al.
Publicado: (2016)

Expression of estrogen and progesterone receptors in vestibular schwannomas and their clinical significance
por: Jaiswal, Sushila, et al.
Publicado: (2009)

Expression of estrogen and progesterone receptors in astrocytomas: a literature review
por: Tavares, Cléciton Braga, et al.
Publicado: (2016)

Estrogen and Progesterone hormone receptor expression in oral cavity cancer
por: Grimm, Martin, et al.
Publicado: (2016)

Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea
por: Ahn, Hwa Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_61p25viuf7q2g6fe0ng1svkc1p